From: Hospital utilization rates for influenza and RSV: a novel approach and critical assessment
Country | Age group | BIRD rate per 100,000 (95% UI) | ICD-coded rate per 100,000 (95% UI) |
---|---|---|---|
Ecuador | < 1 year | 64.5 (6–260.9) | 9.8 (9.1–10.6) |
Ecuador | 1 to 4 | 56.5 (4.3–210) | 5.5 (5.2–5.8) |
Ecuador | 5 to 17 | 22.1 (2.2–75.5) | 1.5 (1.4–1.6) |
Ecuador | 18 to 49 | 12.8 (1.7–39.6) | 1.8 (1.7–1.8) |
Ecuador | 50 to 64 | 10 (1–39.1) | 2.4 (2.2–2.6) |
Ecuador | 65 plus | 10.5 (0.8–42.7) | 3.4 (3.1–3.7) |
Georgia | < 1 year | 50.3 (6.5–375.9) | 16.2 (9.7–22.7) |
Georgia | 1 to 4 | 54 (7.3–385.5) | 22.5 (18.8–26.1) |
Georgia | 5 to 17 | 46.2 (8–219.6) | 6.8 (5.6–8) |
Georgia | 18 to 49 | 23.5 (4–87.6) | 2.8 (2.4–3.3) |
Georgia | 50 to 64 | 19.8 (2.4–107.2) | 2.8 (2.1–3.5) |
Georgia | 65 plus | 7.9 (0.9–64.8) | 2.8 (2–3.6) |
India | < 1 year | 11.1 (1–46.4) | 0.6 (0.6–0.7) |
India | 1 to 4 | 14.9 (1.5–59.8) | 1.1 (1.1–1.1) |
India | 5 to 17 | 10.5 (1.2–35.1) | 0.2 (0.2–0.2) |
India | 18 to 49 | 16.6 (2–47.7) | 3.7 (3.7–3.7) |
India | 50 to 64 | 10.2 (1–40.8) | 3.8 (3.7–3.8) |
India | 65 plus | 5.9 (0.5–25.4) | 3.9 (3.8–3.9) |
Mexico | < 1 year | 98.4 (10.3–458.1) | 4.3 (4.1–4.5) |
Mexico | 1 to 4 | 87 (9.3–388.3) | 7.1 (7–7.2) |
Mexico | 5 to 17 | 22.8 (3–74) | 1.9 (1.9–2) |
Mexico | 18 to 49 | 6.6 (0.9–21.6) | 0.8 (0.8–0.8) |
Mexico | 50 to 64 | 8.4 (0.9–33.2) | 1.5 (1.4–1.5) |
Mexico | 65 plus | 7.3 (0.7–32.7) | 1.3 (1.2–1.4) |
New Zealand | < 1 year | 58 (6–231.5) | 15.7 (13.3–18.1) |
New Zealand | 1 to 4 | 131.6 (13.6–482.9) | 46.7 (44.6–48.8) |
New Zealand | 5 to 17 | 18.1 (2.7–54) | 5.7 (5.3–6.1) |
New Zealand | 18 to 49 | 25.4 (3.8–66.7) | 5.7 (5.5–6) |
New Zealand | 50 to 64 | 13.6 (1.5–50.1) | 5.5 (5.1–5.9) |
New Zealand | 65 plus | 11.3 (1–50.2) | 10.5 (9.8–11.2) |
Philippines | < 1 year | 104.4 (11.4–394.8) | 11.6 (10.7–12.5) |
Philippines | 1 to 4 | 288.2 (32.6–1024) | 53.7 (52.6–54.7) |
Philippines | 5 to 17 | 390.7 (60.8–1007.2) | 66.2 (65.5–66.8) |
Philippines | 18 to 49 | 110.6 (18.8–267.5) | 16.3 (16–16.6) |
Philippines | 50 to 64 | 91.4 (10.7–310.1) | 14.5 (14–15) |
Philippines | 65 plus | 42.5 (3.9–179.1) | 12.3 (11.6–13.1) |
Sweden | < 1 year | 128.5 (11.1–523.3) | 25.2 (22.8–27.7) |
Sweden | 1 to 4 | 60.1 (6.9–294.4) | 22.3 (21.2–23.5) |
Sweden | 5 to 17 | 11.6 (1.8–82.7) | 4.8 (4.5–5.1) |
Sweden | 18 to 49 | 12 (2.1–63.8) | 3.5 (3.3–3.6) |
Sweden | 50 to 64 | 5.5 (0.7–41.9) | 5.9 (5.6–6.2) |
Sweden | 65 plus | 5.8 (0.6–41.7) | 16.9 (16.2–17.5) |
Turkey | < 1 year | 50.8 (4.9–205.6) | 1.3 (0.8–1.8) |
Turkey | 1 to 4 | 284.7 (28–1137) | 8.4 (7.8–9) |
Turkey | 5 to 17 | 130.3 (16.5–400.1) | 2.2 (2.1–2.4) |
Turkey | 18 to 49 | 28.9 (4.1–83.5) | 2.3 (2.2–2.4) |
Turkey | 50 to 64 | 23.2 (2.4–90.7) | 2.6 (2.4–2.8) |
Turkey | 65 plus | 15.3 (1.4–68.9) | 5.6 (5.2–6.1) |
United States of America | < 1 year | 168.4 (16.2–714.1) | 139.5 (138.4–140.7) |
United States of America | 1 to 4 | 43.4 (4.4–175.8) | 36.1 (35.8–36.4) |
United States of America | 5 to 17 | 16.6 (2.3–54.5) | 7.2 (7.1–7.3) |
United States of America | 18 to 49 | 27.8 (4.1–80.9) | 4.8 (4.8–4.8) |
United States of America | 50 to 64 | 31.6 (3.4–122.6) | 9.6 (9.5–9.6) |
United States of America | 65 plus | 27 (2.5–122.6) | 32 (31.8–32.2) |